Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableUnknownNCT05507489
What this trial is testing

Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

Who this might be right for
COVID-19Child, Only
The Affiliated Hospital of Qingdao University 240
Not applicableLooking for participantsNCT04362150
What this trial is testing

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

Who this might be right for
COVID
University of California, San Francisco 800
Not applicableUnknownNCT05682612
What this trial is testing

Prognostic Value of PtcO2 in Patients With COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Southeast University, China 40
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Large-scale testing (Phase 3)Study completedNCT05648110
What this trial is testing

Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 3,882
Not applicableUnknownNCT04479982
What this trial is testing

Microbial Infection and AMR in Hospitalized Patients With Covid 19

Who this might be right for
Covid19
Assiut University 70
Not applicableStudy completedNCT04456556
What this trial is testing

Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)

Who this might be right for
Endophthalmitis and Orbital Cellulitis
Minia University 5
Not applicableStudy completedNCT05648799
What this trial is testing

Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia)

Who this might be right for
PharmacokineticsSafety IssuesEfficacy
Geropharm 246
Large-scale testing (Phase 3)UnknownNCT04323345
What this trial is testing

Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus

Who this might be right for
COVID-19
Misr University for Science and Technology 1,000
Not applicableStudy completedNCT04356144
What this trial is testing

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

Who this might be right for
Disseminated Intravascular CoagulationCritical IllnessSars-CoV2+3 more
Medical University of Vienna 58
Post-approval studies (Phase 4)Study completedNCT04405999
What this trial is testing

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

Who this might be right for
Increased Risk of SARS-CoV-2 Infection
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 50
Testing effectiveness (Phase 2)Ended earlyNCT04415073
What this trial is testing

Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19

Who this might be right for
CoronavirusCOVIDARDS+2 more
Syndax Pharmaceuticals 1
Testing effectiveness (Phase 2)UnknownNCT05205083
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Early research (Phase 1)UnknownNCT05526183
What this trial is testing

Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine

Who this might be right for
COVID-19
Ankara City Hospital Bilkent 36
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT04342897
What this trial is testing

LY3127804 in Participants With COVID-19

Who this might be right for
COVID-19Pneumonia
Eli Lilly and Company 95
Testing effectiveness (Phase 2)WithdrawnNCT05702788
What this trial is testing

Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)

Who this might be right for
COVID-19Pneumonia
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Not applicableUnknownNCT04768413
What this trial is testing

Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fundación Universitaria de Ciencias de la Salud 200
Next Page